Houston biotech co. raises nearly $19 million in equity


Solugen Inc., a biotechnology company based in Houston and Philadelphia, recently raised nearly $19 million in equity, according to documents filed with the U.S. Securities and Exchange Commission Nov. 1. Solugen has raised $18.8 million in equity from 50 different investors, though the identities of the investors were not disclosed in the filing. The date of first sale for the new offering was listed as Oct. 17, 2018.



from Biotech News